Evidence map›Paper›PMID 39002961›Full record

ArticleBMJ open2024

Defining indicators for disease burden, health outcomes, policies and barriers and facilitators to health services for migrant populations in the Middle East and North African region: a protocol for a suite of systematic reviews.

Farah Seedat, Stella Evangelidou, Moudrick Abdellatifi, Oumnia Bouaddi, Alba Cuxart-Graell, Hassan Edries, Eman Elafef, Taha Maatoug, Anissa Ouahchi, Liv Mathilde Pampiri and 19 more

Abstract read
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Farah SeedatSt George's University of London Institute for Infection and Immunity, London, UK.ORCID 0000-0002-3563-7875
Stella EvangelidouBarcelona Institute for Global Health, Barcelona, Catalunya, Spain.
Moudrick AbdellatifiUniversité Mohammed VI des Sciences et de la Santé, Casablanca, Casablanca-Settat, Morocco.
Oumnia BouaddiUniversité Mohammed VI des Sciences et de la Santé, Casablanca, Casablanca-Settat, Morocco.ORCID 0000-0001-9114-6889
Alba Cuxart-GraellBarcelona Institute for Global Health, Barcelona, Catalunya, Spain.
Hassan EdriesUniversity of Gezira, Wad Madani, Sudan.ORCID 0000-0002-3114-6358
Eman ElafefUniversity of Gezira, Wad Madani, Sudan.
Taha MaatougUniversity of Sousse, Sousse, Tunisia.
Anissa OuahchiUniversity of Sousse, Sousse, Tunisia.
Liv Mathilde PampiriBarcelona Institute for Global Health, Barcelona, Catalunya, Spain.
Anna DealSt George's University of London Institute for Infection and Immunity, London, UK.
Sara AriasBarcelona Institute for Global Health, Barcelona, Catalunya, Spain.
Adel AbdelkhalekBadr University in Cairo, Cairo, Egypt.
Ahmed Hamed ArishaBadr University in Cairo, Cairo, Egypt.
Bouchra AssaragEcole Nationale de Santé Publique, Rabat, Morocco.
Ibrahim Ahmed BaniAjman University, Ajman, UAE.
Aasmaa ChaouiMinistère de la Santé, Rabat, Morocco.
Wafa Chemao-ElfihriEcole Nationale de Santé Publique, Rabat, Morocco.
Kenza HassouniUniversité Mohammed VI des Sciences et de la Santé, Casablanca, Casablanca-Settat, Morocco.ORCID 0000-0002-7605-895X
Mahmoud HilaliUniversity of Gezira, Wad Madani, Sudan.
Mohamed KhalisUniversité Mohammed VI des Sciences et de la Santé, Casablanca, Casablanca-Settat, Morocco.ORCID 0000-0003-4639-049X
Wejdene MansourUniversity of Sousse, Sousse, Tunisia.
Ali MtiraouiUniversity of Sousse, Sousse, Tunisia.
Kolitha WickramageInternational Organization for Migration, Berlin, Germany.
Dominik ZennerQueen Mary University of London, London, UK.
Ana Requena-Mendez *Barcelona Institute for Global Health, Barcelona, Catalunya, Spain.ORCID 0000-0002-4422-241X
Sally Hargreaves *St George's University of London Institute for Infection and Immunity, London, UK shargrea@sgul.ac.uk.
Mena Migrant Health Working GroupBarcelona Institute for Global Health, Barcelona, Catalunya, Spain.
MENA Migrant Health Working Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe Middle East and North African (MENA) region is characterised by high and complex migration flows, yet little is known about the health of migrant populations, their levels of underimmunisation and access to healthcare provision. Data are needed to support regional elimination and control targets for key diseases and the design and delivery of programmes to improve health outcomes in these groups. This protocol describes a suite of seven systematic reviews that aim to identify, appraise and synthesise the available evidence on the burden and health outcomes, policies and access (barriers and facilitators) related to these mobile populations in the region.

methodsSeven systematic reviews will cover three questions to explore the: (1) burden and health outcomes, (2) policies and (3) healthcare barriers and facilitators for the following seven disease areas in migrants in the MENA region: tuberculosis, HIV and hepatitis B and C, malaria and neglected tropical diseases, diabetes, mental health, maternal and neonatal health, and vaccine-preventable diseases. We will search electronic databases for studies in any language (year 2000-2023), reference-check relevant publications and cross-check included studies with experts. We will search for grey literature by hand searching key databases and websites (including regional organisations and MoH websites) for country-specific guidelines and talking to our network of experts for local and regional reports and key datasets. We will assess the studies and policies for their quality using appropriate tools. We will meta-analyse the data by disease outcome if they are of sufficient volume and similarity. Where meta-analysis is not possible and where data are on policy or access, we will narratively synthesise the evidence using summary tables, figures and text. DISSEMINATION: We anticipate disseminating the findings through peer-reviewed publications, conferences and other formats relevant to all stakeholders. We are following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and protocols will be registered on International Prospective Register of Systematic Reviews.

Indexed as

Health PolicyHealth Services AccessibilitySystematic Reviews as TopicTransients and MigrantsAfrica, NorthernHumansMiddle EastResearch DesignEPIDEMIOLOGYHealth policyMENTAL HEALTHPublic healthPUBLIC HEALTHSystematic Review

Identifiers

PMID39002961
PMCPMC11255408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.